| Name | Title | Contact Details |
|---|
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nations medical research agency — making important discoveries that improve health and save lives.
Kooth is a company that provides online mental health services to over 15.1 million people internationally.
Medsphere is leading a revolution in healthcare information technology applications, significantly and positively impacting the way healthcare institutions enhance patient safety, improve clinical efficiency and increase healthcare quality.